What is the appropriate starting dose of hydroxyzine for an adult with anxiety‑induced insomnia?

Hydroxyzine is Not Recommended for Anxiety-Induced Insomnia

Hydroxyzine should not be used as a first-line treatment for insomnia, including anxiety-induced insomnia, as it lacks evidence-based support and carries significant risks. The American Academy of Sleep Medicine 2017 guidelines explicitly recommend against using antihistamines like diphenhydramine for insomnia treatment 1, and hydroxyzine, being a similar first-generation antihistamine, falls into this category of medications that should be avoided.

Why Hydroxyzine Should Be Avoided for Insomnia

The evidence against hydroxyzine for sleep is compelling:

• No guideline support: Major sleep medicine guidelines do not recommend hydroxyzine for insomnia treatment 1, 2
• Limited efficacy data: A 2023 systematic review found only mixed efficacy for sleep measures across just 5 small studies totaling 207 patients 3
• Significant safety concerns: The FDA label warns about QT prolongation, Torsade de Pointes, CNS depression, and acute generalized exanthematous pustulosis (AGEP) 4
• Anticholinergic burden: Particularly problematic in elderly patients, causing confusion, falls, and cognitive impairment 4

What Should Be Used Instead

For anxiety-induced insomnia, cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment 2. CBT-I demonstrates superior long-term outcomes compared to pharmacotherapy and lacks the adverse effects associated with medications.

If pharmacotherapy is necessary because CBT-I is unavailable or the patient refuses it:

Recommended Options (in order of preference):

1. Low-dose doxepin 3-6 mg at bedtime - specifically FDA-approved for insomnia 2
2. Non-benzodiazepine BZRAs (zolpidem 10 mg, eszopiclone 2-3 mg, zaleplon 10 mg) - for short-term use only 1, 2

For the Underlying Anxiety:

• Address the anxiety disorder separately with appropriate anxiolytics (SSRIs/SNRIs for generalized anxiety disorder)
• The insomnia will often improve as anxiety is controlled

If Hydroxyzine Must Be Used (Against Recommendations)

If you encounter a situation where hydroxyzine is being considered despite the lack of evidence:

The FDA-approved dosing for anxiety is 50-100 mg four times daily 4, but studies examining sleep effects used 25-50 mg at bedtime 3, 5.

Practical approach if prescribed:

• Start with 25 mg at bedtime (lower dose to minimize adverse effects)
• Can increase to 50 mg if inadequate response 3, 6
• Use only for short-term treatment (studies evaluated only 4 weeks) 3, 6
• Evening dosing mitigates some daytime psychomotor impairment 5

Critical Safety Precautions:

• Screen for QT prolongation risk factors before prescribing (cardiac disease, electrolyte abnormalities, concomitant QT-prolonging drugs) 4
• Avoid in elderly patients - start at lowest doses if absolutely necessary, monitor for confusion and falls 4
• Counsel about CNS depression - no driving or operating machinery, avoid alcohol 4
• Watch for skin reactions - discontinue immediately if rash develops (AGEP risk) 4
• Reduce doses of other CNS depressants if used concomitantly 4

Common Pitfalls to Avoid

1. Don't use hydroxyzine as a substitute for proper insomnia treatment - it's not evidence-based for this indication
2. Don't prescribe long-term - no data beyond 4 weeks, and antihistamine tolerance develops quickly
3. Don't ignore the underlying anxiety disorder - treat the root cause rather than just the sleep symptom
4. Don't use in patients with cardiac risk factors without careful consideration of QT prolongation risk 4

The bottom line: Prioritize CBT-I, and if medication is needed, use low-dose doxepin or non-benzodiazepine BZRAs rather than hydroxyzine 1, 2.